EFPIA disclosure
Disclosure of Boehringer Ingelheim affiliates in countries with EFPIA member associations.
Search
EFPIA Mission Possible
This new video highlights how treatments once known for type 2 diabetes are now helping to prevent heart failure, stroke or kidney disease.
Europe needs a vibrant research eco-system
At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe.
trust-through-transparency
Transparency is an essential cornerstone of trust in the healthcare industry
EFPIA Transparency Certification signed
2020_EFPIA_Self_Certification_Letter.pdf
2021_EFPIA_Self_Certification_Letter.pdf
EFPIA Disclosure Code
Drug Discovery at Boehringer Ingelheim
Find out more about the drug discovery process at Boehringer Ingelheim
COVID-19: Healthcare Professionals
Faced with COVID-19, everyone has to adjust their private and professional lives. This is especially true for healthcare professionals.
Patient Organizations
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations.
Ethical Business Practices
Suppliers shall conduct their business in an ethical manner and act with integrity.